Good MorningEquity markets pulled back from their new highs on Thursday after a double-shot of news gave the market a dose of reality. The October read of CPI came in above expectations, belying the need for aggressive FOMC rate cuts, while jobless claims data came in at the highest level in two years. The jobless claims raise fear of a recession even while inflation remains hot. At 258,000 weekly new claims, the unemployment data shows a sharp increase in newly jobless Americans but is offset by a decline in total joblessness. The takeaway is that the data remains spotty, and the US economy is on track for a soft landing.
Next week will be challenging for equity markets. Earnings season will continue its ramp to high gear with reports from big pharma and the first of the FAANG names. Netflix is expected to report on Thursday after the market close and has a high bar to beat. More than 90% of the analysts covering Netflix have raised their estimates for the quarter, forecasting a 15% YoY gain in revenue, and whisper numbers are much higher. The question is not whether Netflix can produce value but whether competition and consumer weakness will sap strength and impact the longer-term growth outlook.
Featured: The world's smartest man is in their crosshairs (Porter & Company) 
|
Markets | | | Airline and transportation stocks have been under pressure from weakening consumer discretionary trends lately, especially as inflation is now threatening to spike again after the – arguably premature – interest rate cuts coming from the Federal Reserve (the Fed), being the most aggres... Read the Full Story |
|
|
Stocks | | | European markets opened higher while Asian stocks were mostly lower on Friday, with Chinese markets declining as investors awaited a key briefing about an upcoming stimulus plan this weekend.In early European trading, Germany's DAX added 0.1% to 19,223.88 and France's CAC 40 was up 0.1% at 7,551.77.... Read the Full Story |
|
Markets | | | Small-cap industrial services company AZZ Inc. (NYSE: AZZ) stock rose more than 100% between 2023 and 2024 and can rise another 25% or more over the next year. The rise in share prices is driven by improving business, cash flow, debt reduction, and capital return, which are expected to continue.... Read the Full Story |
|
From Our PartnersWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.
These challenges aren't distant headlines; they're impacting your everyday finances. | | | | Act Now to Secure Your Complimentary Gold & Silver Guide |
|
Markets | | | While the world of e-commerce in the United States and Europe is dominated by Amazon.com Inc. (NASDAQ: AMZN) and arguably shared with Chinese giant Alibaba Group (NYSE: BABA), a new Latin American territory has been taken over by the region’s leading platform instead, with a particular inter... Read the Full Story |
|
Stocks | | | U.S. stocks edged back from their records Thursday after reports showed inflation was a touch warmer last month than expected and more workers filed for unemployment benefits last week. The S&P 500 slipped 0.2%, and the Dow Jones Industrial Average dipped 57 points, or 0.1%, after it likewise s... Read the Full Story |
|
From Our PartnersThe smart money is piling into gold and gold stocks.
There's a backdoor gold play that could deliver 10 TIMES bigger gains than physical gold.
That's why I've put together a special presentation on this opportunity... | | | | you can access it right here. |
|
Markets | | | Domino’s Pizza (NYSE: DPZ) continues to face challenges but is navigating the conditions well. The Q3 results show that the Hungry for MORE strategy continues to pay off, setting the business up for accelerating growth and leveraging bottom-line results when macroeconomic conditions improv... Read the Full Story |
|
Markets | | | Applied Digital Corp. (NASDAQ: APLD) stock has been volatile since it reported earnings after the market closed on October 9. After gaining 4% in after-hours trading, APLD stock moved sharply lower by 12.8% in pre-market trading. However, as of this writing, the stock is up about 6%, but that&rsqu... Read the Full Story |
|
Markets | | | South Korea's central bank on Friday cut its policy rate for the first time in more than four years as pressure to revive a sluggish economy outweighed concerns about the country's level of household debt.The Bank of Korea lowered its key interest rate by a quarter percentage point to 3.25% followin... Read the Full Story |
|
Markets | | | JPMorgan on Friday reported that its net income fell 2% in the third quarter as the bank had to set aside more money to cover bad loans.Net income fell to $12.9 billion from $13.2 billion in the year-ago quarter. However, the New York bank's earnings per share rose to $4.37 from $4.33 because there ... Read the Full Story |
|
Markets | | | Germany's government said Wednesday that its economy, Europe's biggest, is on track to shrink for a second consecutive year — underlining the unpopular administration's troubles as it heads into a difficult election year.The new forecast that gross domestic product will shrink by 0.2% this year comp... Read the Full Story |
|
Friday's Early Bird Stock Of The Day GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and... | Should I Buy GSK Stock? GSK Pros and Cons Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of GSK was last updated on Tuesday, October 01, 2024 at 9:50 PM. Pros- GSK plc has been receiving positive analyst ratings, including strong-buy and buy ratings, indicating confidence in the company's performance and potential growth.
- Recent price targets set by analysts suggest a positive outlook for GSK plc, with an average target of $50.00, potentially indicating room for stock price appreciation.
- Institutional investors like Natixis Advisors LLC have been increasing their stake in GSK plc, which could be seen as a vote of confidence in the company's future prospects.
- GSK plc has a market capitalization of $91.00 billion, indicating it is a significant player in the pharmaceutical industry with potential for stability and growth.
- The company's price-to-earnings ratio of 15.91 and price-to-earnings-growth ratio of 1.42 suggest that GSK plc's stock may be undervalued compared to its growth potential, making it an attractive investment opportunity.
Cons- Despite positive analyst ratings, GSK plc has also received neutral and hold ratings, indicating some uncertainty in the market about the company's future performance.
- The company's stock has a beta of 0.64, suggesting it may be less volatile than the market average, which could potentially limit short-term gains for investors seeking higher returns.
- GSK plc's current stock price of $43.91 may be near its 52-week high of $45.92, which could signal a potential resistance level and limit immediate upside for investors.
- The debt-to-equity ratio of 0.99 for GSK plc indicates a relatively high level of debt compared to equity, which may pose risks in times of economic uncertainty or rising interest rates.
- While institutional investors like Canal Insurance CO have reduced their holdings in GSK plc, it could suggest a lack of confidence in the company's short-term performance or strategic direction.
| | View Today's Stock Pick |
|
No comments:
Post a Comment